Questions Raised In Vietnam About Pair Of HPV Vaccine Approvals
This article was originally published in PharmAsia News
Vietnam authorities are looking into suspicions medical companies lobbied the government unethically to approve two vaccines against cervical cancer. They include Merck's Gardasil and GlaxoSmithKline's Cervarix. Vietnamese cancer associations are raising questions about the lobbying during the approval process for vaccines that may not be as effective as touted in staving off the human papilloma virus often responsible for cervical cancer. A GSK official said its application was the same it has sent to approval authorities in other countries and it made no special effort in Vietnam. But a Health Ministry official said Vietnam should consider the questions about effectiveness of both vaccines and continue to restrict it for women between ages 10 and 55. (Click here for more
You may also be interested in...
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.
Wholesalers are given three more years to set up electronic systems to verify saleable returns under another reprieve from the FDA. Yet the reprieve does not extend to manufacturers, who must respond within 24 hours to wholesalers’ requests to manually verify that a returned product is not suspect.
Agency explains how it will model vaccine authorization process on its licensing process for matters like inspections and lot release.